» Articles » PMID: 19896455

Hepatitis B Vaccines: WHO Position Paper--recommendations

Overview
Journal Vaccine
Date 2009 Nov 10
PMID 19896455
Citations 84
Affiliations
Soon will be listed here.
Abstract

This article presents the WHO recommendations on the use of hepatitis B vaccines excerpted from the recently published Hepatitis B vaccines: WHO position paper. This document replaces the WHO position paper on hepatitis B vaccines published in the Weekly Epidemiological Record in July 2004. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables assessing the level of scientific evidence are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health-policy matters, WHO is issuing a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with the current WHO position concerning their use in the global context. This updated paper reflects the recent recommendations of WHO's strategic Advisory Group of experts on immunization.

Citing Articles

Towards contextualized complex systems approaches to scaling-up hepatitis B birth-dose vaccination in the African region: a qualitative systematic review.

Solomon-Rakiep T, Olivier J, Amponsah-Dacosta E Front Public Health. 2024; 12:1389633.

PMID: 39512716 PMC: 11540787. DOI: 10.3389/fpubh.2024.1389633.


Guidelines for the vaccination of HIV-infected adolescents and adults in South Africa.

Dlamini S, Madhi S, Muloiwa R, von Gottberg A, Moosa M, Meiring S South Afr J HIV Med. 2024; 19(1):839.

PMID: 39449989 PMC: 11500477. DOI: 10.4102/sajhivmed.v19i1.839.


Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon.

Nguwoh P, Ngounouh C, Essomba R, Olinga P, Likeng J, Nguepidjo G Pan Afr Med J. 2024; 47:169.

PMID: 39036018 PMC: 11260054. DOI: 10.11604/pamj.2024.47.169.40369.


HBV in Italian Women's Jail: An Underestimated Problem?.

Geremia N, Giovagnorio F, De Vito A, Martignago L, Fiore V, Rastrelli E J Clin Med. 2024; 13(5).

PMID: 38592679 PMC: 10932425. DOI: 10.3390/jcm13051398.


The efficacy and safety of pegylated interferon α-2b-based immunotherapy for inactive hepatitis B surface antigen carriers.

Ning H, Li K, Peng Z, Jin H, Zhao H, Shang J Eur J Gastroenterol Hepatol. 2023; 35(10):1216-1223.

PMID: 37577817 PMC: 10756704. DOI: 10.1097/MEG.0000000000002627.